BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹240 Cr | ₹176 Cr | ₹100 Cr | ₹36 Cr | ₹6.11 Cr |
What is the latest Total Liabilities ratio of BALAXI PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹240 Cr |
Mar2022 | ₹176 Cr |
Mar2021 | ₹100 Cr |
Mar2020 | ₹36 Cr |
Mar2019 | ₹6.11 Cr |
How is Total Liabilities of BALAXI PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹240 Cr | 35.81 | |
Mar2022 | ₹176 Cr | 77.04 | |
Mar2021 | ₹100 Cr | 177.11 | |
Mar2020 | ₹36 Cr | 488.92 | |
Mar2019 | ₹6.11 Cr | - |
Compare Total Liabilities of peers of BALAXI PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BALAXI PHARMACEUTICALS | ₹655.5 Cr | -2.6% | 3.2% | 13.4% | Stock Analytics | |
ADANI ENTERPRISES | ₹323,236.0 Cr | -7.2% | -12.4% | 56.4% | Stock Analytics | |
REDINGTON | ₹16,319.5 Cr | -4.5% | -6% | 21.6% | Stock Analytics | |
HONASA CONSUMER | ₹13,864.7 Cr | -0.9% | 4% | NA | Stock Analytics | |
MMTC | ₹10,578.0 Cr | -4.8% | -8.3% | 152.6% | Stock Analytics | |
MSTC | ₹5,798.9 Cr | -8.6% | -11.8% | 194.4% | Stock Analytics |
BALAXI PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BALAXI PHARMACEUTICALS | -2.6% |
3.2% |
13.4% |
SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses